Vor Biopharma reports Q3 results, highlights growth strategies
Vor Biopharma Inc. releases Q3 report, showcasing financial performance and growth strategies in the biological products sector.
NextCure announces termination of CMO amid merger plans
NextCure, Inc. terminates Chief Medical Officer Dr. Udayan Guha in preparation for its merger with Avere Therapeutics, highlighting industry trends.
Game Your Game Faces Nasdaq Delisting, Appoints New Director
Game Your Game Inc. risks delisting from Nasdaq after failing to meet bid price requirements, while appointing Veronica V. Montenegro to its board.
Organon & Co. Reports Q3 Results, Highlights Growth
Organon & Co. announces its Q3 results, showcasing growth in the pharmaceutical sector and competitive positioning in the industry.
Aurinia Pharmaceuticals Reports Q3 2026 Results, Raises Guidance
Aurinia Pharmaceuticals announces strong Q3 2026 results with revenue growth and increased guidance, signaling a positive outlook for the pharmaceutical industry.
Azenta announces strategic agreements with Elegen, acquires SynPlexity
Azenta, Inc. enhances its GENEWIZ gene synthesis capabilities through a partnership with Elegen and the acquisition of SynPlexity, boosting its market position.
Imperial Oil reports record Q3 2026 financial results
Imperial Oil Ltd announces record financial results for Q3 2026, showcasing strong performance and significant shareholder returns.
WisdomTree Reports Strong Q3 Results, Declares Dividend
WisdomTree, Inc. announces record AUM and strong Q3 2026 results, declaring a quarterly dividend of $0.03 per share.
Barclays PLC announces $1.25 billion callable notes offering
Barclays PLC has filed to offer $1.25 billion in callable notes, reflecting its strategy to manage capital amid market fluctuations.
Imperial Oil declares fourth quarter dividend of 87 cents
Imperial Oil Ltd announces a quarterly cash dividend of 87 cents per share for Q4 2026, reinforcing its strong financial position in the petroleum refining sector.
Perella Weinberg Partners Reports Q3 Results for 2026
Perella Weinberg Partners announces its Q3 2026 results, highlighting key performance indicators and strategic insights for the finance services industry.
Jones Lang LaSalle Commits $500 Million to Share Buyback
Jones Lang LaSalle Inc. announces a $500 million share repurchase program, reflecting confidence in its financial health and aiming to enhance shareholder value.
Mammoth Energy Reports Strong Q3 Results, Raises Outlook
Mammoth Energy Services, Inc. posts significant Q3 growth, raising its full-year outlook amid a competitive oil and gas field services market.
Gorman-Rupp appoints David J. Daniels Jr. as CAO
Gorman-Rupp Company names David J. Daniels Jr. as Chief Administrative Officer, enhancing its focus on IT and HR functions.
Colgate-Palmolive reports Q3 earnings results for 2026
Colgate-Palmolive Company announces its earnings for Q3 2026, reflecting ongoing operational health in the competitive perfumes and cosmetics industry.
Barclays announces $1 billion callable notes due 2030
Barclays PLC has filed to offer $1 billion in senior callable notes due 2030, a strategic move to enhance its capital structure.
NatWest Group Reports Q3 2026 Interim Management Results
NatWest Group plc releases its Q3 2026 interim management statement, detailing key performance metrics and financial results.
AbbVie reports third-quarter financial results for 2026
AbbVie Inc. announces its third-quarter financial results, showcasing performance metrics that may influence its future in the pharmaceutical industry.
BP PLC reports strong Q3 2026 results, cash generation up
BP PLC's Q3 2026 results show significant cash generation and improved balance sheet health, reflecting resilience in the petroleum refining sector.
FT Select I LLC files new Form D for private equity offering
FT Select I LLC has filed a new Form D, indicating an ongoing private equity fund offering aimed at accredited investors.